ArticleCureus2024
Pituitary Melanoma Metastasis: A Case Report and Literature Review.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metastases to the pituitary gland are a rare finding, with breast and lung being the most common metastases in this anatomical region. Pituitary melanoma metastases reports are thus sparse, and both diagnosis and treatment are challenging. We present the case of a 66-year-old woman with pituitary melanoma metastasis who presented with symptoms of anterior pituitary dysfunction and headache. These symptoms were difficult to manage medically until gross total resection and immunotherapy were carried out. At 17 months post-operative, there was no progression of the underlying disease. A review of the published literature was performed for all the histologically confirmed pituitary melanoma metastases, as well as their clinical presentation, diagnosis, and treatment workout. Our literature review included 18 published cases: the median age was 62, 68% were male, and the median time of melanoma diagnosis to pituitary metastasis diagnosis was 25 months. The most common symptoms were anterior pituitary deficiency, visual disturbances, headache, cranial nerve palsy, and diabetes insipidus. In terms of management, surgery, radiotherapy, and chemotherapy were used alone or in combination. The median overall survival was 9.5 months. These metastases present a great diagnostic and therapeutic challenge since the symptoms are non-specific and there are no available treatment guidelines. Surgery to decompress the adjacent structures allows for symptomatic control and a better quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.